Depression
Feature
Breaking through a ‘cloud of silence’
“When you look after a doctor, you have to be a little suspicious that they may be covering up their suicidality,” said Dr. Michael F. Myers.
Feature
Your colleague appears depressed. Now what?
Experts share tips on how to react when fellow physicians appear depressed or suicidal.
Commentary
Psychiatrists urged to look beyond the ‘monoamine island’
Dr. Munjal G. Shroff issues a challenge to psychiatrists for 2020.
Commentary
Ketamine/esketamine: Putative mechanisms of action
Details of how these agents produce rapid antidepressant effects have been misrepresented.
Evidence-Based Reviews
Top research findings of 2018-2019 for clinical practice
First of 2 parts . These studies may change your approach to treatment-resistant depression, PTSD, and more.
Sponsored Supplement
Depression Across the Spectrum of Mood Disorders: Advanced Strategies in Major Depressive Disorder and Bipolar Disorder
From the Journals
Novel analysis links insomnia to first-onset major depressive disorder
First-onset major depressive disorder was significantly associated with difficulty initiating sleep among individuals in a 6-year prospective...
From the Journals
Heart rate changes during sleep may be diagnostic tool for depression
A heart rate–profiling algorithm shows promise at distinguishing differences in heart rate patterns during sleep between people with depression...
Conference Coverage
Clinic goes to bat for bullied kids
NEW ORLEANS – In Dr. Raffalli’s clinical experience, cyberbullying has become the bully’s weapon of choice.
From the Journals
Brains of MDD patients show alterations in areas tied to positive emotions
“To the best of our knowledge, asymmetric alterations in cortical thickness and subcortical volume in patients with MDD have not yet been reported...
Commentary
Fast-tracking psilocybin for refractory depression makes sense
The FDA also should support the trials of nitrous oxide (laughing gas), and other safe and novel approaches to successfully treat treatment-...
FDA/CDC
FDA fast-tracks psilocybin for major depressive disorder
A nonprofit medical research organization has received a Breakthrough Therapy designation for the psychedelic drug.